Cardinali D. P033 | Double marker strategy to measurable residual disease assessment in Philadelphia-like acute lymphoblastic leukemia: <a href="https://haematologica.org/search/search?query=D.+Cardinali">D. Cardinali</a>1, <a href="https://haematologica.org/search/search?query=F.+Kaiser">F. Kaiser</a>1, <a href="https://haematologica.org/search/search?query=I.+Della+Starza">I. Della Starza</a>1|2, <a href="https://haematologica.org/search/search?query=V.+Bellomarino">V. Bellomarino</a>1, <a href="https://haematologica.org/search/search?query=M.+Di+Trani">M. Di Trani</a>1, <a href="https://haematologica.org/search/search?query=L.+Elia">L. Elia</a>1, <a href="https://haematologica.org/search/search?query=L.+Fucci">L. Fucci</a>1, <a href="https://haematologica.org/search/search?query=L.+Cappelli">L. Cappelli</a>1, <a href="https://haematologica.org/search/search?query=M.+Ansuinelli">M. Ansuinelli</a>1, <a href="https://haematologica.org/search/search?query=M.+Martelli">M. Martelli</a>1, <a href="https://haematologica.org/search/search?query=R.+Foà">R. Foà</a>1, <a href="https://haematologica.org/search/search?query=S.+Chiaretti">S. Chiaretti</a>1 | 1Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome; 2AIL Roma ODV, Italy.. Haematologica;111(s1):; https://doi.org/10.3324/haematol.2026.s1.103.